Sangamo Therapeutics Inc (SGMO) Insider Trading
- $45,174,920.90
- $83,310,269.06
- Sept. 26, 2023
- Ra Capital Management, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 16, 2015 | Major Shareholder | 21,829 | $14.09 | Sell | $307,570.61 | |
| April 15, 2015 | CEO | 25,000 | $15.33 | Sell | $383,250.00 | |
| April 15, 2015 | Major Shareholder | 21,829 | $13.16 | Buy | $287,269.64 | |
| April 14, 2015 | Major Shareholder | 3,055 | $14.78 | Sell | $45,152.90 | |
| April 11, 2015 | Major Shareholder | 116,992 | $14.48 | Buy | $1,694,044.16 | |
| April 10, 2015 | CFO | 12,000 | $15.31 | Sell | $183,720.00 | |
| April 10, 2015 | Major Shareholder | 83,000 | $14.91 | Buy | $1,237,530.00 | |
| April 9, 2015 | Major Shareholder | 69,856 | $16.27 | Sell | $1,136,557.12 | |
| April 8, 2015 | Major Shareholder | 121,876 | $15.49 | Buy | $1,887,859.24 | |
| April 7, 2015 | Major Shareholder | 33,667 | $15.42 | Buy | $519,145.14 | |
| April 6, 2015 | CMO | 15,000 | $14.94 | Sell | $224,100.00 | |
| April 6, 2015 | Director | 2,200 | $14.95 | Sell | $32,890.00 | |
| April 4, 2015 | Major Shareholder | 179,031 | $15.38 | Buy | $2,753,496.78 | |
| April 3, 2015 | Major Shareholder | 195,126 | $16.61 | Buy | $3,241,042.86 | |
| April 1, 2015 | SVP | 15,000 | $15.15 | Sell | $227,250.00 | |
| April 1, 2015 | Major Shareholder | 250,000 | $18.01 | Sell | $4,502,500.00 | |
| March 28, 2015 | Major Shareholder | 84,000 | $17.10 | Buy | $1,436,400.00 | |
| March 27, 2015 | Major Shareholder | 256,187 | $17.65 | Buy | $4,521,700.55 | |
| March 26, 2015 | Major Shareholder | 210,013 | $18.14 | Buy | $3,809,635.82 | |
| March 25, 2015 | Major Shareholder | 84,000 | $19.42 | Buy | $1,631,280.00 | |
| March 21, 2015 | Major Shareholder | 101,808 | $21.22 | Buy | $2,160,365.76 | |
| March 19, 2015 | CFO | 10,000 | $18.00 | Sell | $180,000.00 | |
| March 19, 2015 | Major Shareholder | 17,808 | $24.28 | Sell | $432,378.24 | |
| March 18, 2015 | Major Shareholder | 84,000 | $23.74 | Sell | $1,994,160.00 | |
| March 17, 2015 | Major Shareholder | 52,161 | $23.02 | Buy | $1,200,746.22 | |
| March 16, 2015 | CEO | 25,000 | $17.29 | Sell | $432,250.00 | |
| March 13, 2015 | Major Shareholder | 71,319 | $22.76 | Buy | $1,623,220.44 | |
| March 12, 2015 | Major Shareholder | 123,480 | $23.40 | Sell | $2,889,432.00 | |
| March 10, 2015 | Major Shareholder | 12,522 | $22.30 | Buy | $279,240.60 | |
| March 7, 2015 | Major Shareholder | 258,377 | $22.25 | Buy | $5,748,888.25 | |
| March 6, 2015 | Major Shareholder | 61,483 | $24.10 | Sell | $1,481,740.30 | |
| March 3, 2015 | Major Shareholder | 84,000 | $18.21 | Sell | $1,529,640.00 | |
| March 3, 2015 | Director | 2,200 | $17.21 | Sell | $37,862.00 | |
| March 2, 2015 | SVP | 15,000 | $17.26 | Sell | $258,900.00 | |
| Feb. 28, 2015 | Major Shareholder | 42,000 | $18.10 | Buy | $760,200.00 | |
| Feb. 27, 2015 | Major Shareholder | 32,196 | $19.37 | Sell | $623,636.52 | |
| Feb. 26, 2015 | Major Shareholder | 74,194 | $19.57 | Buy | $1,451,976.58 | |
| Feb. 20, 2015 | Major Shareholder | 35,319 | $18.40 | Sell | $649,869.60 | |
| Feb. 19, 2015 | Major Shareholder | 6,720 | $18.51 | Sell | $124,387.20 | |
| Feb. 18, 2015 | Major Shareholder | 11,172 | $18.11 | Sell | $202,324.92 | |
| Feb. 14, 2015 | Major Shareholder | 15,380 | $18.61 | Sell | $286,221.80 | |
| Feb. 13, 2015 | Major Shareholder | 15,409 | $18.46 | Sell | $284,450.14 | |
| Feb. 12, 2015 | Major Shareholder | 42,000 | $18.04 | Buy | $757,680.00 | |
| Feb. 12, 2015 | Director | 10,000 | $15.00 | Sell | $150,000.00 | |
| Feb. 11, 2015 | Major Shareholder | 42,000 | $19.65 | Buy | $825,300.00 | |
| Feb. 7, 2015 | Major Shareholder | 34,688 | $18.52 | Sell | $642,421.76 | |
| Feb. 6, 2015 | Major Shareholder | 7,312 | $18.42 | Sell | $134,687.04 | |
| Feb. 5, 2015 | Major Shareholder | 42,000 | $18.23 | Buy | $765,660.00 | |
| Feb. 5, 2015 | CMO | 15,000 | $12.93 | Sell | $193,950.00 | |
| Feb. 3, 2015 | Director | 2,200 | $12.70 | Sell | $27,940.00 |
Insiders are both buying and selling Sangamo Therapeutics Inc stock.
The insider traders at Sangamo Therapeutics Inc are: Ra Capital Management, Llc, Henry Ward Wolff, Kathy Yi, Philip D Gregory, Edward R. Conner, Dale G Ando, Edward O Lanphier II, Curt A Herberts III, John William Larson, William R Ringo, Edward Lanphier II, Biogen Inc., Saira Ramasastry, Dale Ando, Philip Gregory, H Stewart Parker, Curt A. Herberts III, Steven J Mento, Paul B Cleveland, Joseph S. Zakrzewski, Steven Mento, Rolf Andrew Ramelmeier, Gary Loeb, Stephen George Dilly, John Markels, Edward R Conner, and Paul Cleveland
The most active insider trader at Sangamo Therapeutics Inc is Ra Capital Management, Llc with 67 trades.
Ra Capital Management, Llc has sold the most Sangamo Therapeutics Inc stock with a total value of $51,828,744.34.
Ra Capital Management, Llc has bought the most Sangamo Therapeutics Inc stock with a total value of $45,450,853.84.
The most recent insider trade for Sangamo Therapeutics Inc was on Sept. 26, 2023.
The single biggest insider buy for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,748,888.25 on March 7, 2015.
The single biggest insider sell for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,241,865.00 on April 22, 2015.